Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma: A REPORT FROM THE LYMPHOMA STUDY GROUP (1984–87)

British Journal of Haematology

Volumn 79, Issue 3, 1991, Pages 428-437

  Shimoyama, M ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMAN; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MIDDLE AGE; OPPORTUNISTIC INFECTIONS; PROGNOSIS; SUPPORT, NON-U.S. GOV'T;

EID: 0026095532     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1991.tb08051.x     Document Type: Article

References (33)

1. Decline of natural cytotoxicity of human lymphocytes following infection with human T‐cell leukemia/lymphoma virus (HTLV)
2. Nonparametric estimation from observations
3. Immune suppression in healthy carriers of adult T‐cell leukemia retrovirus (HTLV‐1): Impairment of T‐cell control of Epstein‐Barr virusinfected B‐cells
4. Variation in the clinical courses of adult T‐cell leukemia
5. Spontaneous, complete remission in adult T‐cell leukemia: a case report
6. Preleukemic state of adult T cell leukemia: abnormal T lymphocytosis induced by human adult T cell leukemia‐lymphoma virus
7. Final results of cooperative study of VEPA [vincristine, cyclophosphamide (Endoxan), prednisolone and adriamycin] therapy in advanced adult non‐Hodgkin's lymphoma: Relation between T‐ or B‐cell phenotype and response
8. Evaluation of survival data and two new rank order statistics arising in its consideration
9. Monoclonal integration of HTLV‐1 proviral DNA in patients with strongyloidiasis
10. Multi‐step carcinogenesis model for adult T‐cell leukemia
11. HTLV‐1 associated myelopathy. a new clinical entity
12. Interpretation of serum calcium in patients with abnormal serum proteins
13. Alteration of T‐cell functions by infection with HTLV‐1 or HTLV‐II
14. Adult T‐cell leukemia‐lymphoma and its clinical subtypes from the viewpoints of viral etiology
15. Importance of immunological and functional classification of non‐Hodgkin's lymphoma to establish their clinicopathological characteristics
16. Comparison of clinical, morphologic and immunologic characteristics of adult T‐cell leukemia‐lymphoma and cutaneous T‐cell lymphoma
17. Atypical adult T‐cell leukemia‐lymphoma: Diverse clinical manifestations of adult T‐cell leukemia‐Iymphoma
18. Major prognostic factors of adult patients with advanced T‐cell lymphoma/leukemia
19. Major prognostic‐factors of patients with adult T‐cell leukemia‐lymphoma: a cooperative study
20. Immunosuppressive factors from adult T‐cell leukemia cells
21. Some problems on the histopathological diagnosis of non‐Hodgkin's malignant lymphoma. A proposal of a new type
22. The third nationwide study on adult T‐cell leukemia/lymphoma (ATL) in Japan: Characteristic patterns of HLA antigen and HTLV‐I infection in ATL patients and their relatives
23. The fourth nation‐wide study of adult T‐cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features
24. Clinical diversity in adult T‐cell leukemia‐lymphoma
25. Adult T‐cell leukemia: clinical and hematologic feature of 16 cases
26. Human T cell leukemia/lymphoma virus‐infected antigen‐specific T cell clones: Indiscriminate helper function and lymphokine production
27. A proposal for smoldering adult T‐cell leukemia (smoldering ATL): a clinicopathologic study of 5 cases
28. Polyclonal intergration of HTLV‐1 proviral DNA in lymphocytes from HTLV‐1 seropositive individuals: an intermediate state between the healthy carrier state and smouldering ATL